252 related articles for article (PubMed ID: 29680002)
1. Improving the utility of clinical phenotyping in interstitial cystitis/painful bladder syndrome: from UPOINT to INPUT.
Crane A; Lloyd J; Shoskes DA
Can J Urol; 2018 Apr; 25(2):9250-9254. PubMed ID: 29680002
[TBL] [Abstract][Full Text] [Related]
2. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.
Nickel JC; Shoskes D; Irvine-Bird K
J Urol; 2009 Jul; 182(1):155-60. PubMed ID: 19447429
[TBL] [Abstract][Full Text] [Related]
3. Adding a sexual dysfunction domain to UPOINT system improves association with symptoms in women with interstitial cystitis and bladder pain syndrome.
Liu B; Su M; Zhan H; Yang F; Li W; Zhou X
Urology; 2014 Dec; 84(6):1308-13. PubMed ID: 25312548
[TBL] [Abstract][Full Text] [Related]
4. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity.
Shoskes DA; Nickel JC; Dolinga R; Prots D
Urology; 2009 Mar; 73(3):538-42; discussion 542-3. PubMed ID: 19118880
[TBL] [Abstract][Full Text] [Related]
5. Phenotype-directed management of interstitial cystitis/bladder pain syndrome.
Nickel JC; Irvine-Bird K; Jianbo L; Shoskes DA
Urology; 2014 Jul; 84(1):175-9. PubMed ID: 24813068
[TBL] [Abstract][Full Text] [Related]
6. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
Shoskes DA; Nickel JC; Kattan MW
Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
[TBL] [Abstract][Full Text] [Related]
7. Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity.
Samplaski MK; Li J; Shoskes DA
J Urol; 2012 Nov; 188(5):1788-93. PubMed ID: 22998916
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome.
Hedelin HH
Scand J Urol Nephrol; 2009; 43(5):373-6. PubMed ID: 19921982
[TBL] [Abstract][Full Text] [Related]
9. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age.
Rais-Bahrami S; Friedlander JI; Herati AS; Sadek MA; Ruzimovsky M; Moldwin RM
BJU Int; 2012 May; 109(9):1356-9. PubMed ID: 21883848
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of erectile domain to UPOINT phenotype does not improve correlation with symptom severity in men with chronic prostatitis/chronic pelvic pain syndrome.
Samplaski MK; Li J; Shoskes DA
Urology; 2011 Sep; 78(3):653-8. PubMed ID: 21664651
[TBL] [Abstract][Full Text] [Related]
11. The role of cystoscopy in the diagnosis of Hunner's ulcer disease.
Braunstein R; Shapiro E; Kaye J; Moldwin R
J Urol; 2008 Oct; 180(4):1383-6. PubMed ID: 18707698
[TBL] [Abstract][Full Text] [Related]
12. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of the UPOINT phenotype system in Chinese males with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a prospective study.
Zhao Z; Zhang J; He J; Zeng G
PLoS One; 2013; 8(1):e52044. PubMed ID: 23349680
[TBL] [Abstract][Full Text] [Related]
14. Use of the UPOINT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study.
Guan X; Zhao C; Ou ZY; Wang L; Zeng F; Qi L; Tang ZY; Dun JG; Liu LF
Asian J Androl; 2015; 17(1):120-3. PubMed ID: 25248659
[TBL] [Abstract][Full Text] [Related]
15. An online UPOINT tool for phenotyping patients with chronic prostatitis.
Tran CN; Li J; Shoskes DA
Can J Urol; 2014 Apr; 21(2):7195-200. PubMed ID: 24775571
[TBL] [Abstract][Full Text] [Related]
16. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes.
Shoskes DA; Nickel JC; Rackley RR; Pontari MA
Prostate Cancer Prostatic Dis; 2009; 12(2):177-83. PubMed ID: 18645581
[TBL] [Abstract][Full Text] [Related]
17. Is a sexual dysfunction domain important for quality of life in men with urological chronic pelvic pain syndrome? Signs "UPOINT" to yes.
Davis SN; Binik YM; Amsel R; Carrier S
J Urol; 2013 Jan; 189(1):146-51. PubMed ID: 23164384
[TBL] [Abstract][Full Text] [Related]
18. Clinical phenotyping of urologic pain patients.
Kartha GK; Kerr H; Shoskes DA
Curr Opin Urol; 2013 Nov; 23(6):560-4. PubMed ID: 24080805
[TBL] [Abstract][Full Text] [Related]
19. Clustering of Patients with Interstitial Cystitis/Bladder Pain Syndrome and Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Lai HH; Thu JHL; Moh FV; Paradis A; Vetter J
J Urol; 2019 Sep; 202(3):546-551. PubMed ID: 30916629
[TBL] [Abstract][Full Text] [Related]
20. Distribution of the positive UPOINT domain in patients with chronic prostatitis or chronic pelvic pain syndrome: A multicenter observational study.
Ichihara K; Takahashi S; Hiyama Y; Masumori N; Nagae H; Ito S; Wada K; Betsunoh H; Hamasuna R; Togo Y; Shigemura K; Takeyama K
J Infect Chemother; 2022 May; 28(5):631-634. PubMed ID: 35101387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
